Lercanidipina Farmoz

Lercanidipine, the active ingredient in Lercanidipina Farmoz, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension by relaxing arterial smooth muscle and lowering blood pressure in adult patients. GNH USA supplies Lercanidipina Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lercanidipine is used to manage conditions related to elevated blood pressure.

Hypertension: reduces systolic and diastolic blood pressure by relaxing arterial smooth muscle, helping to prevent cardiovascular complications.

Lercanidipine may cause a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Headache: mild to moderate headache often occurring at treatment initiation. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: light‑headed sensation, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Angio‑edema: rapid swelling of face, lips, tongue or throat requiring urgent care. - Myocardial infarction: rare occurrence of heart attack in susceptible patients.

When prescribing Lercanidipine, clinicians should consider the following precautions.

Monitor blood pressure: adjust dose if target levels are not achieved. Assess liver function: use with caution in hepatic impairment. Avoid in patients with severe aortic stenosis: risk of hypotension. Caution in elderly: increased sensitivity to vasodilatory effects. Store at ambient temperature: keep in original container, protect from moisture and light.

Lercanidipine can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels and risk of hypotension. - Co‑administration with other antihypertensives (e.g., ACE inhibitors, diuretics) without monitoring: can cause excessive blood pressure drop. - Use with grapefruit juice: enhances drug exposure leading to adverse effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response. - Alcohol: can potentiate vasodilatory effects, increasing dizziness.